Maple Rock Capital Partners »

Teva Pharmaceutical Industries shares owned by Maple Rock Capital Partners

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Maple Rock Capital Partners from 13F filings

Historical chart of Maple Rock Capital Partners investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Maple Rock Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Maple Rock Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $27M 2.6M 10.44

More positions owned by Maple Rock Capital Partners

Western Digital (WDC)
Lyft Cl A Com Call Option (LYFT)
Jd.com Spon Adr Cl A Call Option (JD)
Spirit Aerosystems Hldgs Com Cl A (SPR)
Arch Resources Cl A (ARCH)
Reliance Steel & Aluminum Put Option (RS)
Ringcentral Cl A (RNG)
Alibaba Group Hldg Sponsored Ads (BABA)
Bausch Plus Lomb Corp Common Shares (BLCO)
Las Vegas Sands (LVS)
Triumph (TGI)
Algoma Stl Group (ASTL)
Kosmos Energy (KOS)
Tripadvisor Call Option (TRIP)
Baidu Spon Adr Rep A (BIDU)

View all positions for Maple Rock Capital Partners

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Arrowstreet Capital, Limited Partnership
Sphera Funds Management

View all funds holding Teva Pharmaceutical Industries